Pfizer Inc. Looks to Expand R&D Presence in Asia

HONG KONG, Nov 30 (Reuters) - Pfizer Inc (PFE.N: Quote, Profile, Research), the world's biggest drug maker, wants to expand its research and development activities in Asia, targeting China, India, Japan, and South Korea, an executive said on Friday. Pfizer, who makes blockbuster anti-cholesterol drug Lipitor and the erectile dysfunction drug Viagra, opened a research centre in Shanghai in 2005 and aims to expand clinical research activities globally, with nearly 80 studies ongoing.